{"protocolSection":{"identificationModule":{"nctId":"NCT02895737","orgStudyIdInfo":{"id":"290/16s"},"organization":{"fullName":"Deutsches Herzzentrum Muenchen","class":"OTHER"},"briefTitle":"PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device","officialTitle":"PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device","acronym":"PROTECT"},"statusModule":{"statusVerifiedDate":"2021-01","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-12-28","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2022-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2016-09-06","studyFirstSubmitQcDate":"2016-09-06","studyFirstPostDateStruct":{"date":"2016-09-12","type":"ESTIMATED"},"lastUpdateSubmitDate":"2021-03-02","lastUpdatePostDateStruct":{"date":"2021-03-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Deutsches Herzzentrum Muenchen","class":"OTHER"}},"descriptionModule":{"briefSummary":"This prospective, randomized study was designed to analyse the difference of cerebral embolization in patients undergoing transcatheter aortic valve implantation with balloon-expandable vs. self-expandable valves by using a cerebral protection system (Sentinel™ Device)."},"conditionsModule":{"conditions":["Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves"],"keywords":["aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"SUPPORTIVE_CARE","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":328,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"balloon-expandable TAVI without cerebral protection","type":"OTHER","description":"Patient receives a balloon-expandable transcatheter aortic valve replacement without cerebral protection","interventionNames":["Device: TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra"]},{"label":"balloon-expandable TAVI with cerebral protection","type":"OTHER","description":"Patient receives a balloon-expandable transcatheter aortic valve replacement with cerebral protection","interventionNames":["Device: TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra; Sentinel™ Cerebral Protection Systems"]},{"label":"self-expandable TAVI without cerebral protection","type":"OTHER","description":"Patient receives a self-expandable transcatheter aortic valve replacement without cerebral protection","interventionNames":["Device: TAVI: CoreValve® Evolut R™, CoreValve Medtronic"]},{"label":"self-expandable TAVI with cerebral protection","type":"OTHER","description":"Patient receives a self-expandable transcatheter aortic valve replacement with cerebral protection","interventionNames":["Device: TAVI: CoreValve® Evolut R™, CoreValve Medtronic; Sentinel™ Cerebral Protection Systems"]}],"interventions":[{"type":"DEVICE","name":"TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra","armGroupLabels":["balloon-expandable TAVI without cerebral protection"]},{"type":"DEVICE","name":"TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra; Sentinel™ Cerebral Protection Systems","armGroupLabels":["balloon-expandable TAVI with cerebral protection"]},{"type":"DEVICE","name":"TAVI: CoreValve® Evolut R™, CoreValve Medtronic","armGroupLabels":["self-expandable TAVI without cerebral protection"]},{"type":"DEVICE","name":"TAVI: CoreValve® Evolut R™, CoreValve Medtronic; Sentinel™ Cerebral Protection Systems","armGroupLabels":["self-expandable TAVI with cerebral protection"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Total new lesion volume in protected brain regions detected by Magnetic Resonance Imaging (MRI)","timeFrame":"Day 2-4 post-procedure"}],"secondaryOutcomes":[{"measure":"Number of new cerebral lesions detected by MRI","timeFrame":"Day 2-4 post-procedure"},{"measure":"Occurrence of clinical stroke and/or neurocognitive dysfunction as assessed by neurological and neurocognitive assessments","timeFrame":"Day 2-4 post-procedure; 6 months post-procedure"},{"measure":"Postoperative Outcome according to the VARC 2 criteria","timeFrame":"from operation until hospital discharge; 30-days, 6-months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with aortic stenosis and indication for transfemoral aortic valve replacement\n* Freedom of significant stenosis in the area of Truncus brachiocephalicus and left A. carotis (CT)\n* Necessary vessel diameter of 6.5-10 mm in the area of A. carotis communis sinistra and 9-15 mm in the area of Truncus brachiocephalicus (for delivery of protection system)\n* Anomalies of aortic arch (\"bovine arch\" variants):\n\n  1. Direct outflow of left A. carotis communis out of Truncus brachiocephalicus\n  2. Conjoint origin of Truncus brachiocephalicus and left A. carotis communis out of aortic arch\n* The patient has provided written informed consent\n\nExclusion Criteria:\n\n* Apoplexy/ TIA during the last ½ year\n* Severe carotid stenosis (\\>70%)\n* Symptomatic or asymptomatic carotid stenosis with necessity of TEA or stenting\n* Relevant psychiatric diseases\n* Severe/ relevant visual, auditory or cognitive deficits which impede targeted anamnesis, neurologic evaluation or consenting.\n* Severe neurodegenerative or progressive neuromuscular disease and state after severe craniocerebral injury with permanent neurologic sequelae and structural cerebral diseases\n* Pronounced kinking/ stenosis or calcification in the area of the right A. radialis/ brachialis/ subclavia, which impede implantation of the cerebral protection system\n* Significant stenosis, relevant calcifications, dissections or aneurysmatic alterations in the area of Truncus brachiocephalicus and/or A. carotis communis sinistra.\n* Contraindications for MRI: among others the presence of a non-MRI-compatible pacemaker or defibrillator, metal implants in the area to be evaluated, metal fragments in the craniocerebral area, allergies, claustrophobia.\n* Vessel alterations which impede among others the introduction of a 6 French sheath:\n\n  1. Inadequate perfusion in the area of the right upper extremity (pathologic Allen´s test, vessel obstructions, peripheral vascular disease)\n  2. Hemodialysis shunt, grafts, or arteriovenous fistulas in the area of right upper extremity\n* Acute myocardial infarction ≤ 1 month prior to the planned procedure\n* Every contraindication for the execution of a transfemoral TAVI\n* Aortic annulus \\<19 or \\>29 mm\n* Combined aortic vitium with predominant insufficiency.\n* Severly reduced leftventricular function ≤ 20%\n* Patients who are planned for a hybrid procedure (e.g. conventional operation and TAVI or simultaneous coronary intervention at coronary artery disease needing intervention) 14 days prior to the planned study procedure\n* Intracardiac thrombus, hematoma, tumor or vegetations confirmed by echocardiography\n* Endocarditis\n* Planned concomitant procedure for atrial fibrillation (operative or via catheter ablation) during the follow up phase\n* Need for emergency procedure\n* Chronic drug-, medication or alcohol abuse\n* Consuming disease\n* Life expectancy \\< 1 year\n* Dialysis dependency\n* Patient with legal incapacity, who is not able to understand the essence, meaning and consequences of the study\n* Participation in other interventional clinical trials in the month of study start or planned participation during the participation of this study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Stephanie Voss, Dr.","role":"CONTACT","phone":"0049 89 1218 0","email":"VossS@dhm.mhn.de"}],"locations":[{"facility":"Deutsches Herzzentrum Muenchen, Klinik für Herz- und Gefäßchirurgie","status":"RECRUITING","city":"Muenchen","state":"Bayern","zip":"80636","country":"Germany","contacts":[{"name":"Stephanie Voss, Dr.","role":"CONTACT","phone":"00498912180"}],"geoPoint":{"lat":51.60698,"lon":13.31243}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M4030","name":"Aortic Valve Stenosis","relevance":"LOW"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M6165","name":"Constriction, Pathologic","relevance":"LOW"},{"id":"T449","name":"Aortic Valve Stenosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}